title: Can intravenous cyclophosphamide be used for steroid-dependent nephrotic syndrome?
authors.forename: Z
authors.initials: Z
authors.lastname: Bircan
authors.forename: M
authors.initials: M
authors.lastname: Soran
authors.forename: M
authors.initials: M
authors.lastname: Kervancioglu
authors.forename: G
authors.initials: G
authors.lastname: Gonlusen
authors.forename: I
authors.initials: I
authors.lastname: Tuncer
mesh_terms: D000477:Alkylating Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D002675:Child, Preschool; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007223:Infant; D008297:Male; D009402:Nephrosis, Lipoid / Q000139:chemically induced / Q000188:drug therapy*; D013256:Steroids / Q000009:adverse effects*
chemical_list: D000477:Alkylating Agents; D013256:Steroids; D003520:Cyclophosphamide